Sath Shukla, CEO & President at Spero Therapeutics, Inc. (SPRO), sold 261,741 shares at $0.78 ($204K) on 2025-02-05, disclosed to the SEC on 2025-02-05.
Seasonal sale ($204k) by CEO & President — this insider has traded SPRO in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.78 | 6,139 | $5K | 2.3% |
| 2 | $0.78 | 42,786 | $33K | 16.3% |
| 3 | $0.78 | 106,408 | $83K | 40.7% |
| 4 | $0.78 | 106,408 | $83K | 40.7% |
| Total | $0.78 avg | 261,741 | $204K | 100% |
| Filing → |
| SPRO | SELL | 2024-02-05 | $173K | — | Filing → |
| SPRO | SELL | 2023-08-30 | $8K | — | Filing → |
| SPRO | SELL | 2023-02-03 | $17K | — | Filing → |